OpenBilldrug price receipt

NADAC week of 2026-10-14

DEFERASIROX 360 MG TABLET

For 30 tablets

Pharmacies pay

$37.42 filed

30 × $1.24749 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: The Part D file flags this drug’s average spending per dosage unit as an outlier, so OpenBill does not use it as a reference price. Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$48.03 estimated

$37.42 + $5.61 (15%) + $5.00 fee per fill = $48.03

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DEFERASIROX 360 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as deferasirox.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Camber Pharmaceuticals, Inc., Dr. Reddy's Laboratories Inc and Aurobindo Pharma Limited.

FDA’s Established Pharmacologic Class for it is Iron Chelator.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $37.42 for 30 tablets (30 × $1.24749 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 8 labelers

LabelerNDCsPharmacies pay per unit
Alembic Pharmaceuticals Inc.1$1.24749 per EA filed
Ascend Laboratories, LLC1$1.24749 per EA filed
Aurobindo Pharma Limited1$1.24749 per EA filed
Camber Pharmaceuticals, Inc.1$1.24749 per EA filed
Dr. Reddy's Laboratories Inc1$1.24749 per EA filed
NorthStar Rx LLC1$1.24749 per EA filed
Xiromed, LLC1$1.24749 per EA filed
Zydus Pharmaceuticals USA Inc.1$1.24749 per EA filed
All 8 NDCs, with labeler and price
  • 31722-0013-30 · Camber Pharmaceuticals, Inc. · $1.24749 per EA · eff. 2026-09-23 filed
  • 43598-0851-30 · Dr. Reddy's Laboratories Inc · $1.24749 per EA · eff. 2026-09-23 filed
  • 59651-0412-30 · Aurobindo Pharma Limited · $1.24749 per EA · eff. 2026-09-23 filed
  • 62332-0412-30 · Alembic Pharmaceuticals Inc. · $1.24749 per EA · eff. 2026-09-23 filed
  • 67877-0554-30 · Ascend Laboratories, LLC · $1.24749 per EA · eff. 2026-09-23 filed
  • 70700-0271-30 · Xiromed, LLC · $1.24749 per EA · eff. 2026-09-23 filed
  • 70710-1277-03 · Zydus Pharmaceuticals USA Inc. · $1.24749 per EA · eff. 2026-09-23 filed
  • 72603-0233-01 · NorthStar Rx LLC · $1.24749 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name deferasirox with DEFERASIROX 360 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
DEFERASIROX 180 MG TABLET
generic · tablet, film coated / tablet
$0.875 per EA filed
eff. 2025-10-22
We don’t know yet
DEFERASIROX 360 MG TABLET this page
generic · tablet, film coated / tablet
$1.24749 per EA filed
eff. 2026-09-23
We don’t know yet

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-10-22, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.